July 14, 2025
Tag: Leukemia Clinical Program
June 16, 2025
ASCO Post: Revumenib in Triplet Regimen Under Study in Newly Diagnosed AML With NPM1/KMT2A Alterations
June 12, 2025
Novel drug combination is safe and benefits people with acute myeloid leukemia who have a specific genetic profile
Joshua Zeidner, MD, and colleagues report that a combination therapy that adds a recently approved drug to the current standard of care for newly diagnosed acute myeloid leukemia showed high rates of complete remission in an early-phase clinical trial.
March 31, 2025
Adaptive whole-genome sequencing could transform childhood leukemia diagnosis
UNC Lineberger researchers have demonstrated a faster, more cost-effective approach to analyzing the genetic makeup of pediatric acute leukemia. Determining a cancer’s genomic classification is critical to developing a more effective treatment plan tailored to a patient’s tumor.
February 10, 2025
ASCO Post: Novel Menin Inhibitors Show Safety and Activity in Several Clinical Trials
November 13, 2024
EMJ Podcast: Insights For Healthcare Professionals: Hema Now: Episode 4: Navigating Acute Myeloid Leukaemia
September 30, 2024
New treatments offer promise to people with acute myeloid leukemia
Joshua Zeidner, MD, a hematologist/oncologist specializing in the management of acute leukemia, explains some of the advances in the treatment of acute myeloid leukemia (AML).
October 18, 2023
Cancer Therapy Next: CAR-T may move more patients with CLL ‘toward a potential cure’
January 23, 2023
Daily Tar Heel: After cancer treatment, UNC diver Emily Grund makes her return to the pool
April 26, 2022
Nanotechnology offers lower cost, high accuracy approach to diagnosing leukemias in low resource countries
A newer, less expensive nanotechnology may make it possible to more accurately diagnose children with acute leukemia in lower income countries, according to findings by Thomas Alexander, MD, MPH, and colleagues.